Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
08/18/2005 | US20050181359 Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
08/18/2005 | US20050180992 Fabricating wet spun or electrospun fibers using nanometer scale liquid crystalline viral particle suspensions where particle composition and function can be modified genetically to include binding or nucleating conjugate moieties while maintaining fibrous structure end product |
08/18/2005 | DE102004004043A1 Reinigung von hochmolekularen Verbindungen mittels Affinitätsmembranchromatographie Purification of high molecular weight compounds by means of affinity membrane chromatography |
08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
08/17/2005 | EP1563834A1 Hollow nanoparticles of protein and drug using the same |
08/17/2005 | EP1407006B1 Method for the recovery and purification of poxviruses from infected cells |
08/17/2005 | EP1066372B1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same |
08/17/2005 | EP0636172B1 Genetically engineered attenuated viruses |
08/17/2005 | CN2717963Y Ultra high-pressure virus inactivating device |
08/17/2005 | CN1655827A Novel use of adenoviruses and nucleic acids coding therefor |
08/17/2005 | CN1654665A Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
08/17/2005 | CN1654658A Combined application of gp64 gene and p35 gene of baculovirus |
08/17/2005 | CN1654638A Method for constructing weak strain of plant virus |
08/17/2005 | CN1654637A Interferential RNA retrovirus and its preparation and use |
08/17/2005 | CN1215082C Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
08/16/2005 | US6929941 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
08/16/2005 | US6929798 Compositions and methods for treatment of microbial infections |
08/16/2005 | CA2224257C Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
08/16/2005 | CA2086936C Method for producing members of specific binding pairs |
08/11/2005 | WO2005072364A2 A modified baculovirus expression system for production of pseudotyped raav vector |
08/11/2005 | WO2005072214A2 Improved inactivated fcv vaccines |
08/11/2005 | WO2005072129A2 Production of host cells containing mutiple integrating vectors by serial transduction |
08/11/2005 | WO2004057021A3 Molecular methods and compositions for detecting and quantifying respiratory viruses |
08/11/2005 | WO2003088899A3 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof |
08/11/2005 | US20050176146 Using vector transformation to generate heat resistant viral particles |
08/11/2005 | US20050176130 Functional mutations in respiratory syncytial virus |
08/11/2005 | US20050176129 Adenovirus vector |
08/11/2005 | US20050176128 Method for assembling subunits into capsoids |
08/11/2005 | US20050175991 Using fluid comprising bacteria lysing virus bacteria as tool in cleaning fruits and vegatables |
08/11/2005 | US20050175985 Cold-adapted equine influenza viruses |
08/11/2005 | US20050175633 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV |
08/11/2005 | US20050175632 Vaccine for preventing cervical cancer |
08/11/2005 | US20050175594 Myoviridae; also used to treat animals infected with Listeria monocytogenes |
08/11/2005 | US20050175589 Anti-neoplastic viral agents |
08/11/2005 | CA2553989A1 Production of host cells containing mutiple integrating vectors by serial transduction |
08/11/2005 | CA2553805A1 Improved inactivated feline calicivirus vaccines |
08/11/2005 | CA2548992A1 Immunotherapy compositions, method of making and method of use thereof |
08/10/2005 | EP1561819A1 Method of transferring gene into t cells |
08/10/2005 | EP1561817A2 Modified CEA and uses thereof |
08/10/2005 | EP1561758A1 Method for isolating and purifying viruses from plant sources |
08/10/2005 | EP1560491A2 Bacteriophage having modified holin and uses thereof |
08/10/2005 | EP1336088B1 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
08/10/2005 | EP0597852B2 Swine pneumonia vaccine and method for the preparation thereof |
08/10/2005 | CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
08/10/2005 | CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
08/10/2005 | CN1653182A Recombinant fowlpox virus |
08/10/2005 | CN1653181A Expression of genes in modified vaccinia virus ankara by using the cowpox ATI promoter |
08/10/2005 | CN1653176A Compositions and methods for generating an immune response |
08/10/2005 | CN1653172A Cotton rat lung cells for virus culture |
08/10/2005 | CN1652819A Attenuation of metapneumovirus |
08/10/2005 | CN1651573A New Aike 30 Virus and its use |
08/10/2005 | CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
08/04/2005 | WO2005071093A2 Chimpanzee adenovirus vaccine carriers |
08/04/2005 | WO2005071085A1 Process for producing virus vector |
08/04/2005 | WO2005071084A1 Construction of gutted recombinant adenovirus effectively expressing antibodies comprising human constant region and uses thereof |
08/04/2005 | WO2005071069A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
08/04/2005 | WO2005071068A1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS |
08/04/2005 | WO2005070953A1 Purification of high-molecular compounds by means of affinity membrane chromatography |
08/04/2005 | WO2005070454A2 A novel process of hepatitis a vaccine preparation |
08/04/2005 | WO2005001059A3 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
08/04/2005 | WO2004092360A3 The severe acute respiratory syndrome coronavirus |
08/04/2005 | US20050172357 Insect viruses and their uses in protecting plants |
08/04/2005 | US20050172343 Astrocyte modulated genes and uses thereof |
08/04/2005 | US20050170336 Using genetic engineering to prepare virus having plurality of recognition sites for selective binding or nucleating; synthesis of trifunctionalized viral particles for use as field effect transistors |
08/04/2005 | US20050169939 Produced in cultured cells without Marek's disease contamination |
08/04/2005 | US20050169890 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase |
08/04/2005 | CA2554198A1 Process for producing virus vector |
08/04/2005 | CA2553756A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
08/04/2005 | CA2553541A1 Chimpanzee adenovirus vaccine carriers |
08/04/2005 | CA2547757A1 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
08/03/2005 | EP1558726A1 Vaccines against west nile virus |
08/03/2005 | EP1558724A2 Organellar targeting of rna and its use in the interruption of environmental gene flow |
08/03/2005 | EP1558643A2 T cell receptor display |
08/03/2005 | EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
08/03/2005 | EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
08/03/2005 | EP0702719B1 Process for the sterilization of biological compositions and the product produced thereby |
08/03/2005 | CN1650021A Stable adenoviral vectors and methods for propagation thereof |
08/03/2005 | CN1648260A Use of SARS coronary virus ORF8 region |
08/03/2005 | CN1648254A Goose parvo-virus VP1 and VP3 gene non-overlapping sequence pronucleus expression protein and its preparing method |
08/03/2005 | CN1213068C Improvments in or relating to immune responses to HIV |
08/02/2005 | US6924144 Method and means for producing high titer, safe, recombinant lentivirus vectors |
08/02/2005 | US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara |
08/02/2005 | US6924095 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
08/02/2005 | US6923971 Vaccines |
08/02/2005 | US6923970 Retrovirus-like particles made non-infectious by a plurality of mutations |
08/02/2005 | US6923969 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
07/28/2005 | WO2005068639A2 Particle-induced ghrelin immune response |
07/28/2005 | WO2005067643A2 Determination of hepatitis c virus genotype |
07/28/2005 | WO2005067543A2 Murine calicivirus |
07/28/2005 | WO2005067506A2 Method for monitoring and generating high capacity gutless adenoviral vector |
07/28/2005 | WO2005067478A2 Recombinant icosahedral virus like particle production in pseudomonads |
07/28/2005 | WO2005051433B1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
07/28/2005 | US20050166287 Mag1 nucleic acid molecules and their uses |
07/28/2005 | US20050166286 Use of naturally occurring antimicrobial polypeptides isolated from insects induced with plant pathogens; genetic engineering; fungicide |
07/28/2005 | US20050164941 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens |
07/28/2005 | US20050164940 Fus6 family antimicrobial polypeptides and their uses |
07/28/2005 | US20050164939 Nucleotide sequences coding polypeptide associated with the generation of disease resistant plants |
07/28/2005 | US20050164392 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells |
07/28/2005 | US20050164344 Metabotropic glutamate receptor regulator for use in identifying modulator of channel-mediated intracellular calcium mobilization and treatment of nervous system disorders |
07/28/2005 | US20050164175 Respiratory Syncytial Virus; vectors containing heterogeneity genes |